NO122686B - - Google Patents
Download PDFInfo
- Publication number
- NO122686B NO122686B NO16201866A NO16201866A NO122686B NO 122686 B NO122686 B NO 122686B NO 16201866 A NO16201866 A NO 16201866A NO 16201866 A NO16201866 A NO 16201866A NO 122686 B NO122686 B NO 122686B
- Authority
- NO
- Norway
- Prior art keywords
- adrenocorticotropin
- blood
- temperature
- activity
- value
- Prior art date
Links
- 101800000414 Corticotropin Proteins 0.000 claims description 56
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 claims description 56
- 229960000258 corticotropin Drugs 0.000 claims description 56
- 210000004369 blood Anatomy 0.000 claims description 40
- 239000008280 blood Substances 0.000 claims description 40
- 238000000034 method Methods 0.000 claims description 28
- 230000000694 effects Effects 0.000 claims description 17
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 11
- 241000124008 Mammalia Species 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 210000002966 serum Anatomy 0.000 claims description 8
- 210000002381 plasma Anatomy 0.000 claims description 7
- 235000008160 pyridoxine Nutrition 0.000 claims description 7
- 239000011677 pyridoxine Substances 0.000 claims description 7
- 229940011671 vitamin b6 Drugs 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 5
- 239000007858 starting material Substances 0.000 claims description 5
- 241000283690 Bos taurus Species 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 150000003227 pyridoxines Chemical class 0.000 claims description 2
- 102100027467 Pro-opiomelanocortin Human genes 0.000 description 55
- 238000002360 preparation method Methods 0.000 description 16
- 239000000243 solution Substances 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000012888 bovine serum Substances 0.000 description 6
- 241000700159 Rattus Species 0.000 description 5
- 230000004913 activation Effects 0.000 description 5
- 108010010803 Gelatin Proteins 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 206010062767 Hypophysitis Diseases 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 210000003635 pituitary gland Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 239000003638 chemical reducing agent Substances 0.000 description 3
- 238000005194 fractionation Methods 0.000 description 3
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 238000010254 subcutaneous injection Methods 0.000 description 3
- 239000007929 subcutaneous injection Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 239000000275 Adrenocorticotropic Hormone Substances 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 210000004404 adrenal cortex Anatomy 0.000 description 2
- 230000001919 adrenal effect Effects 0.000 description 2
- 210000004100 adrenal gland Anatomy 0.000 description 2
- 230000001780 adrenocortical effect Effects 0.000 description 2
- 239000002156 adsorbate Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 238000010253 intravenous injection Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- XINQFOMFQFGGCQ-UHFFFAOYSA-L (2-dodecoxy-2-oxoethyl)-[6-[(2-dodecoxy-2-oxoethyl)-dimethylazaniumyl]hexyl]-dimethylazanium;dichloride Chemical compound [Cl-].[Cl-].CCCCCCCCCCCCOC(=O)C[N+](C)(C)CCCCCC[N+](C)(C)CC(=O)OCCCCCCCCCCCC XINQFOMFQFGGCQ-UHFFFAOYSA-L 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009858 acid secretion Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- -1 pyridoxine-activated adrenocorticotropin Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- BHZOKUMUHVTPBX-UHFFFAOYSA-M sodium acetic acid acetate Chemical compound [Na+].CC(O)=O.CC([O-])=O BHZOKUMUHVTPBX-UHFFFAOYSA-M 0.000 description 1
- 229960005480 sodium caprylate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- BYKRNSHANADUFY-UHFFFAOYSA-M sodium octanoate Chemical compound [Na+].CCCCCCCC([O-])=O BYKRNSHANADUFY-UHFFFAOYSA-M 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
- F16D—COUPLINGS FOR TRANSMITTING ROTATION; CLUTCHES; BRAKES
- F16D1/00—Couplings for rigidly connecting two coaxial shafts or other movable machine elements
- F16D1/06—Couplings for rigidly connecting two coaxial shafts or other movable machine elements for attachment of a member on a shaft or on a shaft-end
- F16D1/08—Couplings for rigidly connecting two coaxial shafts or other movable machine elements for attachment of a member on a shaft or on a shaft-end with clamping hub; with hub and longitudinal key
- F16D1/09—Couplings for rigidly connecting two coaxial shafts or other movable machine elements for attachment of a member on a shaft or on a shaft-end with clamping hub; with hub and longitudinal key with radial clamping due to axial loading of at least one pair of conical surfaces
- F16D1/093—Couplings for rigidly connecting two coaxial shafts or other movable machine elements for attachment of a member on a shaft or on a shaft-end with clamping hub; with hub and longitudinal key with radial clamping due to axial loading of at least one pair of conical surfaces using one or more elastic segmented conical rings forming at least one of the conical surfaces, the rings being expanded or contracted to effect clamping
Landscapes
- Engineering & Computer Science (AREA)
- General Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Clamps And Clips (AREA)
- Turbine Rotor Nozzle Sealing (AREA)
- Shafts, Cranks, Connecting Bars, And Related Bearings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK121565 | 1965-03-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO122686B true NO122686B (de) | 1971-07-26 |
Family
ID=8102270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO16201866A NO122686B (de) | 1965-03-10 | 1966-03-09 |
Country Status (7)
| Country | Link |
|---|---|
| AT (1) | AT274490B (de) |
| BE (1) | BE677522A (de) |
| CH (1) | CH469207A (de) |
| DE (2) | DE1525376A1 (de) |
| GB (1) | GB1140601A (de) |
| NL (1) | NL6603127A (de) |
| NO (1) | NO122686B (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS604611A (ja) * | 1984-10-11 | 1985-01-11 | 旭硝子株式会社 | 結合構造 |
| DE3816523A1 (de) * | 1988-05-14 | 1989-11-23 | Manfred Schanz | Zentrierelement |
| WO1990002272A2 (en) * | 1988-08-23 | 1990-03-08 | Moxee Innovations Corporation | Shaft positioning and coupling device |
| GB2350878A (en) * | 1999-06-10 | 2000-12-13 | John Rush | Expansion bushes |
-
1966
- 1966-03-08 CH CH331566A patent/CH469207A/de unknown
- 1966-03-08 GB GB1012066A patent/GB1140601A/en not_active Expired
- 1966-03-09 NL NL6603127A patent/NL6603127A/xx unknown
- 1966-03-09 BE BE677522D patent/BE677522A/xx unknown
- 1966-03-09 NO NO16201866A patent/NO122686B/no unknown
- 1966-03-10 AT AT228666A patent/AT274490B/de active
- 1966-03-11 DE DE19661525376 patent/DE1525376A1/de active Pending
- 1966-03-11 DE DE1966R0032460 patent/DE1992803U/de not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| CH469207A (de) | 1969-02-28 |
| DE1992803U (de) | 1968-08-29 |
| AT274490B (de) | 1969-09-25 |
| GB1140601A (en) | 1969-01-22 |
| NL6603127A (de) | 1966-09-12 |
| DE1525376A1 (de) | 1969-07-31 |
| BE677522A (de) | 1966-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bennett et al. | Release of imnumoreactive luteinising hormone-releasing hormone and thyrotrophin-releasing hormone from hypothalamic synaptosomes | |
| Elliott et al. | Methionyl-lysyl-bradykinin, a new kinin from ox blood | |
| Thorburn et al. | Epidermal growth factor: a critical factor in fetal maturation | |
| US4404131A (en) | Method of producing a factor-VIII(AHF)-high-concentrate | |
| O'Riordan et al. | Isolation and chemical properties of porcine parathyroid hormone | |
| Von Euler et al. | Occurrence of a substance P-like polypeptide in fish intestine and brain | |
| Martal et al. | Immunofluorescent localization of ovine placental lactogen | |
| NO122686B (de) | ||
| Maldonado et al. | Cardiodilatin-immunoreactivity in specific atrial granules of human heart revealed by the immunogold stain | |
| GB779493A (en) | Process for the isolation of stable, highly purified gamma globulin preparations | |
| Evans et al. | Concentration of the gonadotropic hormone in pregnant mare's serum | |
| Frieden et al. | Stimulation of rat uterine collagen synthesis by relaxin | |
| Van Heumen et al. | Ultrastructural evidence for synthesis, storage and release of insulin-related peptides in the central nervous system of Lymnaea stagnalis | |
| US3119740A (en) | Process for preparing purified follicle stimulating hormone | |
| Wilhelmi | The Comparative Biochemistry Of Pituitary Growth Hormone: The Seventh Edsel B. Ford Lecture | |
| Yamazaki et al. | Isolation and purification of colostrokinin from bovine colostrum | |
| Chow | The purification and properties of certain protein hormones | |
| US2909468A (en) | Preparation of adrenocorticotrophin | |
| Gjedde | STUDIES OF THE INSULIN-LIKE ACTIVITY OF SERUM: II: Characterization of insulin-like activity of serum protein fractions from normal human subjects | |
| US5484767A (en) | Substantially pure steroidogenesis inducing protein and uses thereof | |
| Okinaka et al. | Studies on the Defense Mechanism of the Body and the Neurohumoral Regulation Report III. On the Relation between the Hormonal Secretion of the Adrenal Cortex and N. Splanchnicus | |
| David et al. | Répartition de la radioactivité sur le D-ribose biosynthétique | |
| GB928681A (en) | Improvements in or relating to the extraction of corticotrophin | |
| Spencer et al. | Thyroid-adrenocortical antagonism and histamine metabolism | |
| Van Heumen et al. | Light and electron microscopic immunocytochemical demonstration of synthesis, storage, and release sites of the neuropeptide calfluxin in Lymnaea stagnalis |